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1060-132 Combination of Aspirin and Clopidogrel Exerts Superior 
Antithrombotic Potency Compared to Warfarin on 
Mechanical Heart Valves in a Rabbit Flow Chamber 
Axel Schiitt. Baerbel Hauroeder, Michael Buerke, Christoph Bickel, Dirk Peetz, Andy 
Campbell, Ferdinand Hundt, J0rgen Meyer, Hans J, Rupprecht, IL Medical Department, 
University Clinic Mainz, Mainz, Germany, Bundeswehrzentra/institut derBundeswehr 
Koblenz, Koblenz, Germany. 
Background: Lifelong oral anticoagulation (oac) is considered to be the gold standard for 
the prevention of thrombembolic events after implantation of artificial heart valves. In 
studies on the prevention of subacute coronary stent thrombosis the combination of aspi- 
rin with ADP-antagonists such as ticlopidine or clopidogrel was found to be more effec- 
tive than oac. The aim of our study is to investigate the efficiacy of the combination of 
aspirin and clopidogrel in the prevention of thrombus formation on artificial valves in an 
experimental animal model compared to an anticoagulation with cumadns. 
Methods: Antithrombotic potency was investigated in a rabbit-model using a perfusion 
chamber regarding the formation of thrombi on leaflets of Sulzer Carbomedics mechani- 
cal heart valves, 
Studies were performed after oral application of clopidogrel and aspirin in group I (n = 11) 
at best for 4 days, after minimal 5 days treatment of warfarin in group II (n = 11) and with- 
out medication in group nl (n = 5). Leaflets from mechanical heart valves were placed in 
a flow chamber. After tracheotomie and mechanical ventilation flow chamber was filled 
with blood in a circuit between art, carotis and v. jugulads. We compared the weight of 
the leaflets before and after the experiment. Further analysis were performed by electron 
microscopy. 
Results: In group III (controls) flow chamber was clotted after about 15 minutes of circula- 
tion. Comparison of weight analysis between group I and II before and after perfusion 
showed a superiority of clopidogrel/aspirin-treatment in preventing thrombus formation 
on leaflets. Mean weight difference in group I (clopidogrel/aspirin) was 11,2 mg com- 
pared to mean weight difference of 17,5 mg in group II (warfarin). 
Analysis by electron microscopy showed less fewer thrombus formation, i.e. deposition 
of platelets, fibrin and erythrocytas, on leaflets exposed to blood from rabbits in group I 
compared to group I1. 
Conclusion: Combination of clopidogrel and aspirin exerted in an experimental animal 
perfusion model compared to anticoagulation with warfarin superior potency in prevent- 
ing thrombus formation on artificial heart valve leaflets. 
1060-133 Role of Serial Troponin Testing for Diagnosis of 
Perioperative Myocardial Infarction After Cardiac 
Surgery 
Staohanie Lehrke, Evangelos Giannitsis, Margit M011er-Bardorff, Henning Steen, Arrnin 
Opitz, Hanno Peters, Uwe KH Wiegand, Hugo A Katus, Medizinische Universit~t zu 
LObeck, L9beck, Germany. 
Background.The value of serial troponin testing for diagnosis of perioperative myocardial 
infarction (MI) after major cardiac surgery is still unsettled. 
Methods, We studied 204 patients undergoing major cardiac surgery, including CABG 
(132/204) and valve surgery (36/204). Cardiac troponin T (cTnT) was measured before 
crossclamping and sedally at 4, 8, 24 hours and once daily thereafter for 7 days. Periop- 
erative MI was defined as new evolving Q-waves on serial ECGs, ROC analysis was per- 
formed to obtain the optimal cTnT discriminator for perioperative MI at different time 
points. 
Results. A total of 13/204 patients suffered a perioperative MI. In these patients, cTnT 
levels at all time-points beyond 8 hours and peak cTnT levels were higher compared to 
patients without pedoperative MI (figure). ROC analysis yielded an optimal discriminator 
above 1.26 pg/L at 24 hours (AUC 0.69,sens 54%, spec 87%). In addition, time to peak 
was higher in patients with perioperative MI (43.4 vs 26.4h, p=0.03). 
Conclusions. Serial cTnT testing may be useful in identifying patients with a pedoperative 
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1060-134 The Utility of the ACCIAHA Guidelines for Screening 
Angiogrephy in Patients Undergoing Surgical Repair for 
Mitral Regurgitation 
Eric Lim, Zied AlL Clifford Barlow, A. R. Hosseinpour, James C. Halstaad, Christopher 
Wisbey, Susan C. Charman, John B. Badow, Francis C. Welts, Papworth Hospital, 
Cambridge, United Kingdom, University of Witwatersrand and Johannesburg Hospital, 
Johannesburg, South Africa. 
Background: As routine screening angiography is performed for the majority of patients 
undergoing mitral repair at our institution, we evaluated the utility of the 1998 ACC/AHA 
guidelines on a review of 400 patients who underwent surgery for mitral regurgitation 
from 1987 to 1999. 
Methods: Coronary angiography was performed and disease defined as lumen narrow- 
ing of >= 50%. Risk factors for coronary disease were: age (males > 35 or females >51 
years), family history, smoking, diabetes, and hypercholeetarolemia. Evaluated ACC/ 
AHA indications were: history of angina / MI and presence of >= 1 risk factor. Etiology 
was determined by histopathology of operative valve specimens. Sensitivity (Sn), speci- 
ficity (Sp) and likelihood ratio positive (LR+) for coronary disease on angiography were 
calculated for each risk. 
Results: Of 400 patients, angiographic details were unavailable in 12 (3%), and 29 
(7.5%) had no angiography due to emergent status (24 with and 5 without defined indica- 
tions). Angiography was performed in 359 (92.5%) patients with a mean age of 65 (± 10) 
years consisting of 234 (65.2%) males. The etiologies for mitral disease were degenera- 
tive (82.7%), rheumatic (7.0%), ischemic (5.6%) and endocarditis (4.7%). 
Prevalence of coronary disease and proportion of concomitant bypass surgery was 
28.1% and 22.3% respectively. 
Proportion of patients fulfilling either indication for angiography was 99.4%, Sn 1.00, Sp 
0.01, LR+ 1.01, with age criterion alone in 98.1%, Sn 1.00, Sp 0.03, LR+ 1.03, Angina 
was present in 30.9%, Sn 0.59, Sp 0.80, LR+ 3.01. 
Of 248 patients without angina or MI, indications were: hypertension in 24.6%, Sn 0.26, 
Sp 0.87, LR+ 1.98; hypercholesterolemia in 43.1%, Sn 0.20, Sp 0.89, LR+ 1.85; smoking 
in 26,6%, Sn 0.24, Sp 0.86, LR+ 1.77; diabetes in 5.6%, Sn 0.21, Sp 0.84, LR+ 1.30 and 
family history in 9.6%, Sn 0.17, Sp 0.83, LR+ 1.01. 
Conclusions: ACC / AHA guidelines have excellent Sn, but very low Sp. Similar result is 
achieved with age as the sole criterion for angiography. Angina was the best predictor of 
coronary disease. Almost all patients quality for angiography, but only a minority had con- 
comitant bypass surgery. More stringent criteria may improve the cost effectiveness of 
the guidelines. 
1060-135 Elevated Serum Interleukin-6 Has Prognostic 
Significance for Postoperative Outcome in Patients 
Undergoing Cardiothoracic Surgery 
Matthew D. Bacchetta. Matthew R. Moore, Daniel M. Levine, Thomas S. Parker, Bruce 
R, Gordon, O. Wayne Isom, Karl H. Kdeger, Leonard N. Girardi, Wilson Ko, Stuart D. 
Saal, New York Presbyterian Hospital-Weill Medical College of Comell University, New 
York, New York, Rogosin Institute at Rockefeller Universi~ New York, New York. 
Inflammatory cytokines become elevated during cardiothoracic surgery procedures. 
Many studies have sought to charactedze the differences in cytokine expression based 
on technical approaches, e.g. pump vs. off-pump CABG surgery. We undertook a pro- 
spective study to investigate the relationship between the inflammatory cytokines, IL-8, 
slL-2R, sTNF-R (p55), and sTNF-R (p75), and clinical outcomes as prognostic predictors 
of post-operative management and outcome in patients (n=65) who had cardiothoracic 
operations. Three sequential blood samples were collected: (1) prior to induction of anes- 
thesia, (2) completion of surgery, and (3) 24-hours after the induction of anesthesia. Pre- 
determined clinical outcome measures included ICU length of stay (ICULOS), total length 
of stay (TOTLOS), post-operative ventilation duration (VentTime), duration of vasopres- 
sor (PressorTime) and inotropic (InotropeTime) requirements, and complication rate. The 
pre-operative cytokine levels did not correlate with the outcome data, however IL-6 levels 
from time points 2 and 3 were found to have independently demonstrated statistically sig- 
nificant prognostic value in regard to the pre-determined outcome measures, ICULOS 
(p<0.01), TOTLOS (p<0.02), Vent'rime (p<0.01), PressorTime (p<0.01), and Inotrope- 
Time (p<0,01). slL-2R, sTNF-R (p55), and sTNF-R (p75) had less influential prognostic 
significance. Operative Bypass time independently showed prognostic value for ICULOS 
(p<0.01), TOTLOS (p<0.01), and PressorTime (p<.01). Elevated levels of cytokines 
cause Systemic Inflammatory Response Syndrome (SIRS) in patients undergoing car- 
diothoracic procedures, which manifest as increased ICULOS, TOTLOS, ventilatory sup- 
port, inotropic and vasopressor requirements. Of the operative variables, bypass time 
had the greatest prognostic value. IL-6 appears to play a major role in mediating post- 
operative outcome and may facilitate decision-making for critically ill cardiothoracic 
patients. 
1060-136 Use of Subeternal Echocardiogrephy in Patients on 
Ventricular Assist Devices: initial Experience 
John D. Blizzard. H. Storm Floten, Mathew Slater, Robert Lowe, David J. Sahn, Anthony 
J. Furnary, Oregon Health & Science University, Portlanc), Oregon. 
Background: Echocardiography is sometimes difficult in postop patients who may have 
dressings, poor windows and are difficult to reposition. Transesophageal echo carries the 
disadvantages of patient stress, respiratory compromise or the need to further sedate 
conscious patients. We have previously reported a dual lumen chest tube drain device 
with a sealed substernal echocardiography (SEE) lumen 36 Fr (SEE-IT® Medtronics 
Corporation) that allows insertion of a 10.2mm non-stedle minimultiplane TEE probe into 
a substernal position where it can be positioned and rotated for cardiac imaging intra- 
and postoperatively. Methods: At OHSU, 5 patients were studied serially for periods of 
up to 5 days with intermittent echo imaging performed by surgeons on their rounds used 
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to aid decision making regarding management, ventdcular assist settings/termination of 
assist. All patients were heart failure patients who had undergone LVAD, BiVAD insertion 
+ concomitant procedures including multiple bypass, grafting, and/or atrioventricular 
valve repair. The SEE tube placed on the anterior RV surface provided optimal windows 
for imaging of RV and LV function as well as color Doppler visualization of valvular regur- 
gitation. Results: All patients tolerated SEE with no alteration of vital signs, and there 
were no complications despite multiple TEE probe introductions; quantitative and qualita- 
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1085-131 Eva luat ion  of  the  Newly Designed Aortic Root 
Prosthesis and the  Role of  Leaf let  Repair  in the  Valve 
Sparing Operat ion  
Mano J. Thubdkar. Kenton J. Zehr, Francis Robicsek, Eric Skipper, Geoffrey Gong, Bratt 
L. Fowler, Heineman Medical Research Laboratory, Carolinas Medical Center, Charlotte, 
North Carolina, Mayo Clinic, Rochester, Minnesota. 
Introduction: A newly designed aortic root prosthesis with compliant sinuses was evalu- 
ated and the role of leaflet repair was studied in the valve sparing operation. 
Methods: In vitro, 8 aortic root prostheses were sewn to 8 normal (human) aortic valves 
and studied in a left heart simulator. In 7 patients, with annuloaortic ectasia and mild to 
severe AI, the aortic root was reconstructed with the prosthesis and the valve was spared 
while on cerdio-pulmonary bypass. The sinus height (Hs), and the valve diameter at the 
sinotubular junction (ST J-D) were measured from patients' TEE. Also, after the aorta and 
the sinuses were excised during surgery, the valve size at the sinotubular junction was 
measured while moving the commissures centrally till adequate leaflet coaptation was 
achieved, and then compared with the "normal" valve size in an adult of similar height 
and weight. 
Results: In vitro, all of the valves spared, using the newly designed aortic root prosthe- 
sis, showed the normal dynamics with no AI. In contrast, in three patients the leaflet free- 
edge had to be shortened to reduce the AI. None of the patients' valves showed com- 
plete competence. Four patients had trace AI and 3 had mild AI. In the normal intact 
valve the ratio Hs/STJ-D was 0.8 - I, in the dilated aortic root it was 0.5 - 0.7, and after 
the valve sparing it was restored to 0.8 - 1. In the patients, the valve size after the aortic 
root excision was 3 - 6 mm larger than that in a similar size adult, indicating that the leaf- 
lets were stretched. 
Conclualona: In the valve sparing operation, one may encounter both the dilated aodic 
root and stretched leaflets. Replacing only the aortic root with a prosthesis will reduce AI, 
but for complete valvular competence shortening of the leaflet free edge may be 
required. The newly designed aortic root prosthesis appears to function well in this proce- 
dure. 
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1085-132 Lipide in Pat ients  With Aor t i c  Valve Replacement: 
Impact of Preoperative Cholesterol and Triglyceride 
Levels  on  the  Degenerat ion  o f  Per icardial  Valve 
Proethesee 
Geore Nollert. Jessica Miksch, Bruno Reichart, Department of Cardiac Surge~ 
University of Munich, Munich, Germany. 
Background: Recent studies demonstrated the influence of cholesterol on the progres- 
sion of aortic stenosis. We hypothesised that high lipid levels may also stimulate the 
degeneration of pericardial heart valves and lead to reoberation due to structural valve 
failure especially in younger patients with high degeneration rates. 
Methods: In 1984 and 1985 246 patients received pericardial aortic heart valves (61% 
male, age 56±11 years) and had preoperative lipid investigations at our institution. These 
patients received a Hancock Extracorporeal valve (HE; n=177) or a Carpantier Edwards 
pericardial valve (CEP; n=4) in aortic or mitral (HE n= 63; CEP n= 30) position. Double 
valve replacement was performed in 29 patients. 
Results: Operative, 1, 5, 10, and 15 years actuarial survival was 90%, 84%, 66%, 48%, 
and 41% respectively. Freedom from reoperation at 5, 10, and 15 years was 75%, 25%, 
and 11%. Patients younger than 60 years who had to be reoperatad within 10 years had 
higher preoperative cholesterol (235 ± 59rag/all vs. 194±39mg/gl; p=0.05) and tdglycedde 
levels (143 ± 61 mg/dl vs. 95 ± 32mg/dl; p=0.035) than those reoperatad after 10 years. 
In order to calculate the influence of preoperative lipid levels on the degeneration rate 
patients were split into quartiles. Patients below 60 years of the lowest and highest cho- 
lesterol quartiles were free of reoperation in 83% vs. 65 %, 40% vs. 0%, and 11% vs.0% 
(p=0.008) at 5, 10, and 15 years. The figures for the lower and higher triglycedde halves 
were 76% vs. 71%, 36% vs. 8%, and 11% vs. 0% (p=0.015). The differences were similar 
for young patients after solitary aortic valve replacement (cholesterol p=0.0019; triglycer- 
ida p=0.08). However, in this subgroup older patients with low cholesterol levels had 
more reoperations than those with high levels (p=0.045). Survival was independent from 
cholesterol levels, but high triglyceride values (>170 rag/all) were related to worse out- 
come (p=0.004). 
Conclusions: Preoperative cholesterol and triglyceride levels are predictors of structural 
valve failure of pericardial valves. Lowedng of triglyceride and cholesterol levels may be 
a new concept to reduce degeneration of pericardial valves in patients younger than 60 
years. 
1 085-133 Outcomes 15 Years After  Valve Rep lacement  With a 
Mechanical Versus Bioproethetic Valve in Patients 
Between 60 and 70 Years of Age 
G. Hanania, P. M. Michel, J. M. Montely, H. Warembourg, O. Nardi, On Behalf of the 
Working Group of Vaivulopathy TheFrench Society of Cardiology, Hopita/Robert 
Ba/langer, Aulnay-sous bois. 
Background: The choice between mechanical prosthesis (MP) and biopresthesis (BP) 
between 60 and 70 years of age remains controversial Methods: in order to document 
this choice a cooperative and retrospective study analyses the outcome of 441 patients 
operated on in 1985. Results: The valvulopathy was aortic, mitral and mitroaortic in 
respectively 244, 134 and 63 patients. MP and BP were implanted respectively 228 
(52%) and 204 (46%) patients; 9 mitroaortic (2%) had both a BP and a MP. The operative 
mortality (27 cases) was 6.1% lower for aortic patients (3.5%) than for mitrel (7%) and 
bivalvular (13%) patients. On follow-up 244 patients (55%) died. The 15 years actuarial 
survival rates are not different for mitral disease between BP (31%) and MP (25%) (ns). It 
is better for aortic MP (47%) than for BP (26%) (p<0.001). The valve related mortality is 
higher for mitrsl valve (MP 28%, BP 25%) than for aortic (MP 17%, BP 16%). The non 
cardiac mortality is higher than the valve related mortality in every group except for mitral 
BP. Primary valve failure occurs for 8% of aortic BP versus 30% of mitral BP. Valve 
related complications concern 22% of aortic BP, 26% of aortic MP, 32% of mitral MP and 
59% of mitral BP. Among the monovaluvular diseases, 15 years actuarial survival rates is 
respectively 47% for women and 34% for men. Conclualon: These results contra indi- 
cate the use of mitral BP before 70 years. For aortic diseases the rate of primary valve 
failure is actually low at 15 years after surgery. Nevertheless in the cohort, half of the 
women and a third of men have reached or have turned eighty. So it seems more advis- 
able to prefer MP to BP before seventy to avoid lata re-operations. 
1085-134 Elevated B-'~Jpe Natrlureti¢ Peptide in Patients With 
Aeymptomatic Aortic Regurgitation and Normal Left  
Ventr icu lar  Systo l i c  Function 
Micah J. Elmer. Deborah Ekery, Vera Rigolin, Maryl Johnson, Mihai Gheorghiade, Robert 
Bonow, William G. Cotfs, Northwestern University Medical School, Chicago, Illinois. 
Background: Chronic aortic regurgitation (AR) imposes a progressive hemodynamic bur- 
den upon the left ventricle (LV). Management is based on symptoms and LV size and 
function. To determine if B-Tybe natduretic beptide (BNP), a hormone secreted by ven- 
tdcular myocytas under strain, may play a role in decision making for patients with AR, 
we measured BNP levels in patients with chronic asymptomatic AR and normal LV sys- 
tolic function. 
Methods: Ten asymptomatic male patients with isolated AR, age 31-70y (48.5 +/- 14.7), 
underwent echocardiography and measurement of serum BNP levels. Standard echcoar- 
diographic parameters were recorded and AR was quantified by the ratio of jet height 
(JH) to LV outflow tract (LVOT) in the parasternal long axis view. Four males age 29-54y 
(40.25 +/- 11.7) with normal echocardiograms sewed as controls. 
Results: There was no significant difference in age or ejection fraction between patients 
and controls. The mean BNP level was neady fourfold higher in patients with AR com- 
pared to controls (23.7 +/- 23.1 vs 6.1 +/- 4.2pg/ml p=.04). Using linear regression analy- 
sis, significant (p<.05) univariats predictors of BNP in patients with AR include: LV mass 
index(r=.75), LV end diastolic volume (r=.68), LV end systolic volume (r=.59), LV end 
